The main risk is sequence, not demand: Amkor must fund
capex, hit Arizona milestones, qualify lines, and then fill them with sticky higher-value programs before pricing pressure or captive alternatives dilute returns. If the company succeeds, scarcity economics improve; if not, investors may get revenue growth without a durable
rerating.